2025ASCO年会即将举行,多项国产创新药成果入选口头报告,包括信达生物、科伦博泰等多个公司的创新药物。国产创新药在全球范围内越来越占优势,建议关注具备高质量创新能力的公司。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.